Thank you #UniteToFight2024 for including me in your speaker list. I am hoping to show you how ME/CFS differs from long COVID and how we can predict the severity of long COVID very early. Hopefully it will help us in developing better treatment strategies.

Our lab website is online now. We hope to update you about our ongoing research through our website. prustylab.org

This an interesting article on the negative effects of excess Fibronectin in Alzheimer's disease. Our data on high Fibronectin in the serum of ME/CFS and long COVID patients is getting more and more interesting. link.springer.com/article/10.100…

“Good ideas can come from well-researched experimental plans, but they can also come from something as vague as an informed intuition. So, it is crucial at times to trust your training and knowledge, and to take a leap.”

- 2021 medicine laureate Ardem Patapoutian

#NobelPrize

Let's make it blue. My support is for #LightUpTheNight4ME

Simple yet effective - 'The simplest methods can bring about the most effective changes'.

The multifaceted role of mitochondria in Inflammatory diseases. A great read. nature.com/articles/s4158…

Time to rethink the concept of infectious triggers behind a disease. This paper is a good learning tool for all those who think viral particles, viral proteins, and viral DNA and RNA in the blood are a must for a virus-induced disease. nature.com/articles/s4146…

It’s a new year that brings new challenges, new hope, and a new beginning. It’s time to say goodbye to Germany (for the time being) and take up a new challenge at Riga Stradins University. More to follow after 1st April 2024....

Excellent day, full of exciting science on ME and long COVID. I am glad that my work was highly appreciated. Looking forward to public engagement from tomorrow evening and my open talk for all of you on Friday.

He was my first post-doctoral mentor. Together with him, I learned to enjoy science rather than just doing it as a career. He taught me to be excited with unexpected results rather than searching for expected results. I am going to miss him. R.I.P.

We are a small group started working in 2022 on a topic, which is a tough nut to crack. And now we are going out as a team to Charite, Berlin tomorrow with loads of awesome data. If by any chance you are attending the meeting, then come by to meet us in person.

A massive paper writing effort is done and the draft is now sent to all the co-authors. Hoping to submit it soon. If you know my work, then you know how to expect a unique flavor in our results, which was never tried before. Fingers crossed.

Finally, the most awaited week is here. Stop 1 will be Berlin with 15 minutes of talk covering ME/CFS, long COVID, herpes, autoimmunity, a unique serum protein that usually helps in complement pathway but is not doing its job as it should be, how it ties with Lyme, TLR4, ROS etc.